NDC 0206-8860-01 - Zosyn in Galaxy Containers
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0206-8860
- Requested NDC
- 0206-8860-01
- Package NDCs from labels
- 0206-8860-01, 0206-8860-02
- Manufacturer
- Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Yuhan Chemical Inc. | Baxter Healthcare Corporation
- Effective date
- 2023-03-15
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Zosyn in Galaxy Containers | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Yuhan Chemical Inc. | Baxter Healthcare Corporation | 2023-03-15 | HUMAN PRESCRIPTION DRUG LABEL |
| Zosyn in Galaxy Containers | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Yuhan Chemical Inc. | Baxter Healthcare Corporation | 2022-04-18 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0206-8860-02 | 2024-01-30 | C162847 | 48780-1 | 1030e365-1c1d-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use ZOSYN safely and effectively. See full prescribing information for ZOSYN. ZOSYN ® (piperacillin and tazobactam) injection, for intravenous use Initial U.S. Approval: 1993 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0206-8860-01 | Zosynin Galaxy Containers | 50 mL in 1 BAG | INJECTION, SOLUTION | 50 | 1 | |
| 0206-8860-02 | Zosynin Galaxy Containers | 24 in 1 BOX | INJECTION, SOLUTION | 24 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 0206-8860 | ZOSYN IN GALAXY CONTAINERS (TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM) INJECTION, SOLUTION [WYETH PHARMACEUTICALS LLC, A SUBSIDIARY OF PFIZER INC.] | 1 | Current NDC, Legacy NDC, 2 package rows | 20230324_8ab9d90d-2f7f-4599-a44f-3d0a8f8ab623.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0206-8860-01 | ML - Milliliter | 0206-8860 | 1c667819-5f78-4325-b740-e58d7025049f | 1 | 2012-07-24 |
| 0206-8860-02 | ML - Milliliter | 0206-8860 | 1be69a9e-a557-415e-904e-a59e50ef7222 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dextrose | DEXTROSE MONOHYDRATE | Henry Schein, Inc. | 40fd1ac4-39bb-45fb-ba99-4fb65481f231 | 2026-04-09 | Warnings, Adverse reactions | LX22YL083G |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID | Chartwell Governmental & Specialty RX, LLC | 58c24504-47de-487a-ab8d-18add155ea95 | 2026-04-07 | Adverse reactions | 1Q73Q2JULR |
| Sodium Bicarbonate | SODIUM BICARBONATE | Hospira, Inc. | ea9f4498-0d43-4043-8dd1-f22537841c21 | 2026-04-06 | Warnings, Adverse reactions | 8MDF5V39QO |
| Sodium Bicarbonate | SODIUM BICARBONATE | Hospira, Inc. | 8664c7ce-707b-4c6c-9ce4-7160b5f877f8 | 2026-04-06 | Warnings, Adverse reactions | 8MDF5V39QO |
| KIDS TOOTHPASTE, FOR CAVITY PROTECTION | KIDS TOOTHPASTE FOR CAVITY PROTECTION | Shulisa (Foshan) Daily ChemicalIndustry Co., Ltd | 4e8fab9e-f05c-5e2f-e063-6294a90aecf9 | 2026-04-03 | Warnings | 059QF0KO0R |
| Omeprazole/Bicarbonate | OMEPRAZOLE AND SODIUM BICARBONATE | Proficient Rx LP | 4d642036-7175-4f29-9f07-dbd282231d4a | 2026-04-01 | Warnings, Adverse reactions | 8MDF5V39QO |
| Rapidol Sodium Bicarbonate | SODIUM BICARBONATE | Pharmadel LLC | b4c9a653-6f51-7c98-e053-2995a90ada37 | 2026-03-26 | Warnings | 8MDF5V39QO |
| Sodium Bicarbonate Antacid | SODIUM BICARBONATE | Aphena Pharma Solutions - Tennessee, LLC | bba7d5bf-c94b-4ee4-a399-9a2818d84c78 | 2026-03-23 | Warnings | 8MDF5V39QO |
| Sterile Water | WATER | Hospira, Inc. | 2b9ea23a-f9e9-48a8-25b7-519e3bbd6828 | 2026-03-18 | Warnings, Adverse reactions | 059QF0KO0R |
| Dextrose | DEXTROSE MONOHYDRATE | Becton Dickinson and Company | 8e7046f8-841e-465a-af69-af9fb3d6799d | 2026-03-17 | Warnings, Adverse reactions | LX22YL083G |
| TINTED SUNSCREEN FOUNDATION | TINTED SUNSCREEN FOUNDATION | Guanghzou AiXin Biotech Co Ltd | 396393c4-b50c-3877-e063-6294a90a0e9b | 2026-03-17 | Warnings | 059QF0KO0R |
| DEXTROSE | DEXTROSE | HF Acquisition Co. LLC. DBA HealthFirst | 4d2d3d3d-d96e-4005-e063-6394a90afd9a | 2026-03-16 | Warnings, Adverse reactions | LX22YL083G |
| equate omeprazole and sodium bicarbonate | OMEPRAZOLE, SODIUM BICARBONATE | WALMART INC. | c24c3326-99da-4c7d-aecc-7b4a8ac3f04e | 2026-03-15 | Warnings | 8MDF5V39QO |
| Dextrose | DEXTROSE MONOHYDRATE | Fresenius Kabi USA, LLC | 3b8f2692-4371-4f1a-95af-b41842131fdd | 2026-03-13 | Warnings, Adverse reactions | LX22YL083G |
| Skin Irritations and Itch Relief | AGARICUS MUSCARIUS, ALUMINA, ANAGALLIS ARVENSIS, ANTIMONIUM TARTARICUM, APIS MELLIFICA, ARSENICUM ALBUM, ARSENICUM IODATUM, BOVISTA, CAUSTICUM, DOLICHOS PRURIENS, FAGOPYRUM ESCULENTUM, GRAPHITES, KALI MURIATICUM, MURIATICUM ACIDUM, OLEANDER, PETROLEUM, PIX LIQUIDA, RADIUM BROMATUM (12X, 30X, 1LM), RHUS TOX, SELENIUM METALLICUM, SULPHUR AND URTICA URENS. | King Bio Inc. | d139d2f1-0369-4963-9f3d-c4cc0f1ea2dd | 2026-03-10 | Warnings | QTT17582CB |
| 2b19011c-1098-413f-a19b-d90f87ebc92f | e103a5e4-1d0b-4e1f-c69b-774f6ab70df1 | 2026-03-09 | Warnings, Adverse reactions | e103a5e4-1d0b-4e1f-c69b-774f6ab70df1 | ||
| SODIUM BICARBONATE | SODIUM BICARBONATE | Hospira, Inc. | 084f5572-8c1f-4802-b179-ca0cc838fc68 | 2026-03-09 | Warnings, Adverse reactions | 8MDF5V39QO |
| Sodium Bicarbonate | SODIUM BICARBONATE | Hospira, Inc. | 0c24b592-4bc8-456f-acac-9c9525844a06 | 2026-03-09 | Warnings, Adverse reactions | 8MDF5V39QO |
| 2-Pack Facial Serum | 2-PACK FACIAL SERUM | Guangzhou Ariel Biotech Co., Ltd. | 27c7f645-cfb3-6db1-e063-6394a90a42ff | 2026-03-06 | Warnings | 059QF0KO0R |
| Sodium Bicarbonate 5 gr | SODIUM BICARBONATE | TWIN MED LLC | 12cad432-99db-4a9b-8619-82794e29409e | 2026-03-01 | Warnings | 8MDF5V39QO |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.